Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neuronetics Inc STIM

Healthcare Medical Devices
Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength... see more

Recent & Breaking News (NDAQ:STIM)

MT Cap for NeuroStar Advanced Therapy for Mental Health Now Available Nationwide

GlobeNewswire March 1, 2022

Neuronetics to Report Fourth Quarter and Fiscal Year 2021 Financial and Operating Results and Host Conference Call

GlobeNewswire February 22, 2022

Neuronetics Announces Amendment of Credit Facility with SLR Investment Corp.

GlobeNewswire February 22, 2022

NeuroStar Advanced Therapy for Mental Health Recognized as Top Neuromodulation Solution Provider in 2021

GlobeNewswire January 10, 2022

Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results

GlobeNewswire January 10, 2022

Neuronetics Announces 510(k) Clearance of MT Cap Technology for NeuroStar® Advanced Therapy for Mental Health

GlobeNewswire December 20, 2021

Neuronetics Announces Key Role for NeuroStar Advanced Therapy at 4th International Brain Stimulation Conference

GlobeNewswire December 6, 2021

Neuronetics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference

GlobeNewswire November 22, 2021

Neuronetics Reports Third Quarter 2021 Financial and Operating Results

GlobeNewswire November 9, 2021

Neuronetics and River Region Psychiatry Announce Exclusive Partnership

GlobeNewswire November 8, 2021

Anika Appoints Sheryl Conley to Board of Directors

GlobeNewswire November 1, 2021

Neuronetics to Report Third Quarter 2021 Financial and Operating Results and Host Conference Call

GlobeNewswire October 26, 2021

Neuronetics Celebrates 235,000 Treatment Milestone for Success TMS

GlobeNewswire October 26, 2021

CORRECTION - Neuronetics Announces Preliminary Revenue for Third Quarter 2021

GlobeNewswire October 19, 2021

Neuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health

GlobeNewswire October 19, 2021

The Law Offices of Frank R. Cruz Announces Investigation of Neuronetics, Inc. (STIM) on Behalf of Investors

Business Wire October 14, 2021

Neuronetics Announces Preliminary Revenue for Third Quarter 2021

GlobeNewswire October 12, 2021

Neuronetics Announces Commercial Agreement with Success TMS

GlobeNewswire October 5, 2021

NeuroStar® Advanced Therapy Recognizes National Depression Education and Awareness Month With New Campaign Launch

GlobeNewswire October 4, 2021

UPDATE - New Data Highlights NeuroStar® Advanced Therapy for Mental Health Safety Over H-Coil TMS

GlobeNewswire September 22, 2021